<html>
<head>PUBMED IDs for TMED3</head>
<body bgcolor='#C5F0F2'><h1>TMED3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22761906/'>High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22761904/'>Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22761899/'>Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24920608/'>A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.</a> February 11  2014<br></body></html>
